We propose that modulation of Lsd1 activity might be beneficial for short term applications in MSC-based bone tissue engineering, but that long-term use in treatment of cancer or osteoporosis would not be advisable from the perspective of the important function of Lsd1 in normal osteoblast differentiation. Here, KDM1A is linked to cancer.